The application of positron emission tomography (PET) imaging in CNS drug development
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The application of positron emission tomography (PET) imaging in CNS drug development
Authors
Keywords
-
Journal
Brain Imaging and Behavior
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-27
DOI
10.1007/s11682-018-9967-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease
- (2018) Sule Tinaz et al. CLINICAL NUCLEAR MEDICINE
- Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
- (2018) Tanya Simuni et al. MOVEMENT DISORDERS
- 11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study
- (2017) Weihua Li et al. MOVEMENT DISORDERS
- Changing R&D models in research-based pharmaceutical companies
- (2016) Alexander Schuhmacher et al. Journal of Translational Medicine
- Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects
- (2016) Mickael Huiban et al. MOLECULAR IMAGING AND BIOLOGY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Disciplined approach to drug discovery and early development
- (2016) Robert M. Plenge Science Translational Medicine
- Antibody Approaches To Treat Brain Diseases
- (2016) Vera Neves et al. TRENDS IN BIOTECHNOLOGY
- Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
- (2016) Rik Vandenberghe et al. Alzheimers Research & Therapy
- Radioligand development for molecular imaging of the central nervous system with positron emission tomography
- (2014) Michael Honer et al. DRUG DISCOVERY TODAY
- Patients with scans without evidence of dopaminergic deficit: A long-term follow-up study
- (2014) Amit Batla et al. MOVEMENT DISORDERS
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combining PET Biodistribution and Equilibrium Dialysis Assays to Assess the Free Brain Concentration and BBB Transport of CNS Drugs
- (2012) Roger N Gunn et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Confounding Parameters in Preclinical Assessment of Blood–Brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States
- (2012) Anand K. Deo et al. MOLECULAR PHARMACEUTICS
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
- (2010) Walter J. Schulz-Schaeffer ACTA NEUROPATHOLOGICA
- Age-specific progression of nigrostriatal dysfunction in Parkinson's disease
- (2010) Raúl de la Fuente-Fernández et al. ANNALS OF NEUROLOGY
- Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy
- (2010) Sergio Abanades et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis
- (2010) Chris C Tang et al. LANCET NEUROLOGY
- Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative
- (2010) Kewei Chen et al. NEUROIMAGE
- Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
- (2009) R. Nandhagopal et al. BRAIN
- Metabolic correlates of subthalamic nucleus activity in Parkinson's disease
- (2008) Tanya P. Lin et al. BRAIN
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started